World Asset Management Inc grew its position in shares of CME Group Inc (NASDAQ:CME) by 0.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,310 shares of the financial services provider’s stock after purchasing an additional 94 shares during the period. World Asset Management Inc’s holdings in CME Group were worth $4,504,000 at the end of the most recent reporting period.
Other institutional investors have also recently modified their holdings of the company. Advantage Investment Management LLC grew its position in shares of CME Group by 119.0% during the second quarter. Advantage Investment Management LLC now owns 184 shares of the financial services provider’s stock valued at $36,000 after purchasing an additional 100 shares in the last quarter. Westside Investment Management Inc. purchased a new position in shares of CME Group during the second quarter valued at about $38,000. Private Capital Group LLC lifted its holdings in shares of CME Group by 44.9% in the 2nd quarter. Private Capital Group LLC now owns 242 shares of the financial services provider’s stock valued at $40,000 after acquiring an additional 75 shares during the last quarter. Independence Bank of Kentucky bought a new position in shares of CME Group in the 3rd quarter valued at about $40,000. Finally, Garrett Wealth Advisory Group LLC bought a new position in shares of CME Group in the 3rd quarter valued at about $42,000. Hedge funds and other institutional investors own 84.90% of the company’s stock.
NASDAQ CME traded down $4.41 during trading on Tuesday, hitting $201.66. The stock had a trading volume of 1,127,291 shares, compared to its average volume of 1,060,207. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.05 and a current ratio of 1.05. The stock has a market capitalization of $76.33 billion, a price-to-earnings ratio of 29.57, a P/E/G ratio of 4.51 and a beta of 0.20. CME Group Inc has a one year low of $161.05 and a one year high of $224.91. The stock has a 50 day simple moving average of $213.24 and a 200 day simple moving average of $199.04.
CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.75 by $0.01. The business had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.27 billion. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The firm’s quarterly revenue was up 20.1% compared to the same quarter last year. During the same quarter last year, the firm earned $1.74 earnings per share. On average, sell-side analysts predict that CME Group Inc will post 6.79 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Tuesday, September 10th were paid a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.49%. The ex-dividend date was Monday, September 9th. CME Group’s payout ratio is currently 43.99%.
In other news, Director Daniel R. Glickman sold 500 shares of CME Group stock in a transaction that occurred on Wednesday, August 28th. The shares were sold at an average price of $216.01, for a total transaction of $108,005.00. Following the completion of the sale, the director now owns 14,593 shares of the company’s stock, valued at $3,152,233.93. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Terrence A. Duffy sold 35,000 shares of CME Group stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $200.15, for a total transaction of $7,005,250.00. Following the sale, the chief executive officer now directly owns 79,057 shares of the company’s stock, valued at approximately $15,823,258.55. The disclosure for this sale can be found here. In the last three months, insiders sold 57,126 shares of company stock valued at $11,752,684. 1.20% of the stock is owned by insiders.
A number of research analysts recently commented on CME shares. Deutsche Bank increased their price target on shares of CME Group from $224.00 to $240.00 and gave the company a “buy” rating in a report on Friday, August 9th. Berenberg Bank downgraded shares of CME Group from a “buy” rating to a “hold” rating and lowered their price target for the company from $236.00 to $227.00 in a report on Thursday, September 19th. ValuEngine downgraded shares of CME Group from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. BidaskClub downgraded shares of CME Group from a “buy” rating to a “hold” rating in a report on Friday. Finally, Oppenheimer started coverage on shares of CME Group in a report on Monday, September 16th. They issued an “outperform” rating and a $234.00 price target for the company. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $203.14.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Featured Story: Google Finance
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.